News and Announcements
Walker Capital’s BETA launch planned to go live during the first quarter of 2019
- Published January 08, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Walker Capital to launch BETA during the first quarter of 2019.
- The company have expanded and further developed the investment platform.
- New launches on the cards for Walker Capital.
The companies BETA launch is planned to go live during the first quarter of 2019.
This year Walker Capital are planning to launch a Signal Service for Forex and CFDs which is ASIC Licensed and Regulated.
They are working through the final compliance requirements, which will allow them to reduce minimum investment and offer an extensive range of model portfolios.
2018 was an interesting and challenging year for Walker Capital, they made some adjustments to their strategies to suit the current market.
In the last Quarter, they added a Traditional Stock Portfolio in a managed account structure to allow investors to access traditional asset classes to diversify their portfolio’s.
The company have expanded and further developed the investment platform implementing a full digital on-boarding process reducing application time to approx 6 minutes.
Development was undertaken in a number of assets to assist investors to make an informed decision when investing in the companies model portfolios.
This includes their Managed investment Calculator which simulates the returns on our model portfolios based on real trading data.
The 2018 Performance Results
About Walker Capital
Walker Capital is to raise up to $900,000 for 20% in equity. The capital will be used to fund the expansion of the Company as it increases its marketing campaign aimed at expanding its client base and developing an investment platform for its clients.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
